Hematopoietic cell transplantation in the twitcher mouse: The effects of pretransplant conditioning with graded doses of busulfan

Andrew M. Yeager, Charlotte Shinn, Mitsuko Shinohara, Drew M. Pardoll

Research output: Contribution to journalArticlepeer-review

30 Scopus citations


The effects of congenic hematopoietic cell transplantation (HCT; transplantation of bone marrow and spleen cells) after graded doses of busulfan (BU), a myeloablative but nonimmunosuppressive alkylating agent, were evaluated in the twitcher mouse model of human galactosylceramidase deficiency, a demyelinating sphingolipid storage disease. C57BL/6 twitcher mice (immunophenotype Ly-5.1) were given 10 to 50 mg/kg of BU or total-body irradiation (9.0 Gy) at age nine days and HCT from congenic Ly-5.2 donors 24 hr later. The 30-day post-HCT survival, an indicator of tolerance of the preparative regimen, was at least 83% in twitcher mice given 45 mg/kg or less of BU, was 50% in recipients of 50 mg/kg BU and 75% in TBI-conditioned twitchers. The lifespan of twitcher mice given HCT after 10 or 20 mg/kg of BU was similar to that of untreated twitchers (median survival, 42 days; range, 30–47). In contrast, mice transplanted after 35 to 50 mg/kg of BU had significantly prolonged survival (median, 82 days; range, 56–208) and stabilization of hindlimb paralysis, similar to TBI-conditioned recipients. Post-HCT repopulation by donor Ly-5.2 cells was determined by flow cytometry. Thirty days after HCT, only 11–15% of lymphohematopoietic cells in blood, bone marrow, and spleens were of Ly-5.2 donor origin in twitcher mice transplanted after 10 mg/kg of BU but 60–80% were of Ly-5.2 donor origin in mice transplanted after higher doses of BU. These levels further increased to 70–90% by 90 days after HCT, comparable to that seen after TBI. Levels of galactosylceramidase in livers, spleens, and brains of twitchers transplanted after 35–50 mg/kg of BU or after TBI increased to 30–116% of normal control values by 90 days after HCT. Conditioning for HCT with as little as 35 mg/kg of BU provides minimal peritransplant mortality, rapid and sustained establishment of donor lymphohematopoiesis, replacement of lysosomal hydrolase, and prolonged survival in this murine model of human sphingolipidosis.

Original languageEnglish (US)
Pages (from-to)185-190
Number of pages6
Issue number1
StatePublished - Jul 1993

ASJC Scopus subject areas

  • Transplantation


Dive into the research topics of 'Hematopoietic cell transplantation in the twitcher mouse: The effects of pretransplant conditioning with graded doses of busulfan'. Together they form a unique fingerprint.

Cite this